Is lytobi used for bile duct cancer?

What is lytobi's current status in treating bile duct cancer?

Lyti (lyti is short for Tyvyt) but Lytobi does not appear to be an actual drug used in treating cancer according to various sources including DrugPatentWatch.com.[1].

How is lytobi related to other cancer treatments?

There isn't much information on Lytobi which makes it difficult to relate it to other cancer treatments. Some people might be searching for LYT-1 (Lyti) but the term "Lytobi" itself is not recognized according to the DrugPatentWatch Database.

What alternative treatments for bile duct cancer have shown promise?

Imfinzi (Durvalumab) and Keytruda (Pembrolizumab), both checkpoint inhibitors, are being researched for their potential in treating various cancers including bile duct carcinoma. There may be trials going on for the use of these medications in patients with bile duct cancer. Check clinicaltrials.gov or consult a doctor for more information.

When does exclusivity expire for bile duct cancer treatments?

As of now, the patent information for the treatments used for bile duct cancer is not available under the name Lytobi. It's difficult to state an exact expiration date for exclusivity of potential treatments under this name.

References:

[1] DrugPatentWatch.com.